Biotech · Private company
AM-Pharma
Track this companyFree. Adds AM-Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Recombinant human alkaline phosphatasePhase 3 · Acute Kidney Injury Due to SepsisClinicalTrials.gov · fetched Nov 12, 2026
- recAPPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKIPHASE3 · TERMINATED · started Nov 2, 2020ClinicalTrials.gov NCT04411472 · fetched Nov 12, 2026
- A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKIPHASE2 · COMPLETED · started Dec 18, 2014ClinicalTrials.gov NCT02182440 · fetched Nov 12, 2026